NCT00490412已完成不适用
Randomized, Placebo-controlled Trial of the Safety and Effectiveness of Vitamin D Supplement to Improve Tubular Reabsorption of Phosphate and Decrease Bone Turnover in Adolescents and Young Adults With HIV Infection Being Treated With Antiretroviral Therapy Containing Tenofovir Compared to Those Being Treated With Antiretroviral Therapy Not Containing Tenofovir
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 207
- 试验地点
- 29
- 主要终点
- To compare the change in renal tubular reabsorption of phosphate and markers of bone turnover.
研究概览
简要总结
The purpose of this study is to test the effects of Vitamin D on renal phosphate and bone loss, which are common in HIV infected adolescents and young adults being treated with tenofovir.
详细描述
ATN 063 tests the hypothesis that in a population of adolescents and young adults with HIV infection who are being treated with tenofovir as part of an antiretroviral (ARV) combination regimen, vitamin D supplementation will decrease renal phosphate loss, increase plasma phosphate, decrease plasma PTH, and improve markers of bone turnover, including a decrease in plasma N-telopeptide and BAP.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 24 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 years and 0 days through 24 years and 364 days
- •HIV-1 infection as documented by any licensed ELISA test kit and confirmed by Western blot, HIV-1 culture, HIV-1 antigen, plasma HIV-1 RNA, or a second antibody test by a method other than ELISA at any time prior to study entry
- •Currently being treated with a stable FDA-approved ARV combination therapy, containing > 3 antiretrovirals, for > 28 days, according to HRSA guidelines. Treatment regimen will not be started or changed for the purposes of participation in this study. Subjects will be receiving therapy at the direction of their treating physician
- •Willingness to remain on the same ARV combination therapy for the 12-week duration of the study
- •Ability and willingness to participate in the study by providing written informed consent
- •Willingness to be randomized to receive either vitamin D or placebo
排除标准
- •Prior hypersensitivity to vitamin D
- •History of arteriosclerosis, renal stones, glomerulonephritis, nephrotic syndrome, or hypercalcemia
- •Lactation or current pregnancy
- •Active therapy for malignancy
- •Known presence of gastrointestinal disease that would interfere with drug administration or absorption
- •Serological evidence of Hepatitis B surface antigen (HBsAg)
- •Confirmed creatinine clearance < 90 ml/min (calculated GFR from serum creatinine using the MDRD formula)
- •Grade 3 or higher clinical toxicity
结局指标
主要结局
To compare the change in renal tubular reabsorption of phosphate and markers of bone turnover.
时间窗: Baseline, Week 4, Week 12
To measure the safety of 50,000 IU dose of vitamin D3
时间窗: Baseline, Week 4, and Week 8
次要结局
- To measure the change in tenofovir exposure and creatinine clearance(Baseline, Week 4, and Week 12)
- To measure the relationship of tenofovir exposure to renal tubular reabsorption of phosphate and markers of bone turnover(Baseline, Week 4, and Week 12)
- To measure the relationship of vitamin D plasma concentrations to renal tubular reabsorption of phosphate and markers of bone turnover(Baseline, Week 4, and Week 12)
研究者
研究点 (29)
Loading locations...
相似试验
已完成
早期 1 期
High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D StatusBreast NeoplasmsNCT00263185Washington University School of Medicine63
已完成
不适用
Vitamin D Treatment to Patients Suffering From Chronic Pain and Vitamin D HypovitaminosisBack PainHypovitaminosis DNCT01023490Tel-Aviv Sourasky Medical Center12
终止
4 期
Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis CRNA Virus InfectionsFlaviviridae InfectionsHepatitis C, ChronicHepatitis CNCT02120274Federal University of São Paulo85
已完成
4 期
Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 DiabetesType 1 DiabetesNCT01390480Medical University of Graz31
已完成
不适用
The Influence of Vitamin D on Mineral Metabolism, Blood Pressure and Pulse Wave Analysis in Healthy IndividualsHealthyNCT00952562Zealand University Hospital40